Target intelligence / Profile preview

Placental mesenchymal stromal cell (pMSC or PD-MSC)

Target
pMSC or PD-MSC
Molecular classification
Multipotent stromal/stem cell
01

Overview

Placental mesenchymal stromal cells are multipotent, immunomodulatory cells isolated from the placenta, capable of modulating both innate and adaptive immune responses. These cells suppress T cell and B cell responses, promote regulatory T cell formation, and alter the function of antigen-presenting cells through both direct cell–cell interactions and the secretion of immunoregulatory molecules (e.g., TGF-β, IL-10). Due to these properties, placental MSCs are being investigated as therapeutic agents in inflammatory, autoimmune, and transplantation-related diseases, although their precise mechanisms of action and long-term safety require further research.

Other names
Placental mesenchymal stem cellPlacenta-derived mesenchymal stem cellpMSCPD-MSC
02

Mechanism of action

Paracrine secretion of cytokines and growth factors; Promotion of regulatory T cell differentiation; Suppression of dendritic cell maturation and proinflammatory cytokine production; Inhibition of proinflammatory T and B cell activity.

03

Biological functions

Immune response modulationSecretion of immunoregulatory cytokines (e.g., TGF-β, IL-10)Induction of regulatory T cells (Tregs)Inhibition of T and B cell proliferationAlteration of antigen-presenting cell function
04

Disease associations

InflammationGraft-versus-host diseaseAutoimmune diseases (e.g., multiple sclerosis, type 1 diabetes)Transplant rejection
05

Safety considerations

Potential for undesired immunosuppressionRisk of ectopic tissue formation or tumorigenicity (associated with cell therapies)Unclear long-term safety and efficacy in clinical use; needs further validation
06

Biomarkers

FoxP3 (for induced regulatory T cells)CD4, CD25 (for Treg identification in co-culture experiments)Secretion profiles of TGF-β, IL-10, and other cytokines

Beyond the preview

Go deeper on Placental mesenchymal stromal cell (pMSC or PD-MSC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Placental mesenchymal stromal cell (pMSC or PD-MSC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call